TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Predictive Values of Virological Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Occurrence of PE complications
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of HBsAg clearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change of baseline Composite Score for Metabolic Syndrome
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Longitudinal strain value in left Ventricular
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Radial strain value in left Ventricular
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Circumferential strain value in left Ventricular
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: CD8+ immunofluorescence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: CD69+ immunofluorescence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Double CD8+ and CD69+ immunofluorescence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: VASI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in average number of days with headache per month
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functional shoulder results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anorexia Related Preoccupations and Rituals
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Neurologic morbidity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Pain score evaluation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality and Quantity of Sleep
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: APACHE II Severity of Disease Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cardiac Stroke Volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Rate of emergency caesarean section
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Temperature measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in frequency and intensity of suicidal thoughts
Endpoint domain: Adverse events/effects
Primary endpoint: Change in frequency and intensity of suicide attempts
Endpoint domain: Adverse events/effects
Primary endpoint: Total score-change of the Functional Independence Measure (FIM)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change From Baseline in the Mean Asthma Control Questionnaire (ACQ) Score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: PD-L1 expression levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: fMRI - go-nogo task
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: fMRI - monetary incentive delay (MID) task
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Levels of GLP-1 in plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Hypertension medication adherence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: High-sensitivity C reactive protein levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total leukocyte count
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Uric acid seric levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: concentration of hair scalp progesterone
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: concentration of hair scalp estrogen
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Reduction in occurrences of severe diarrhea
Endpoint domain: Adverse events/effects
Primary endpoint: Time to discontinuation of each cohort
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Feasibility
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Visual Comparison of Ecchymosis at Postoperative Day 3
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of Adverse Events (AEs) Related to Study Product
Endpoint domain: Adverse events/effects
Primary endpoint: Anxiety levels measured by Beck Anxiety Inventory
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: recurrence rate of acne
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fructose conversion into lactate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Score of multiple choice question test about radiation hazard knowledge
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Repeatability of lesional PET/CT characteristics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: detectable morphine levels in serum
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Haemostatic balance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Glutamate change from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Glutamate/creatine ratio change from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Parental intentions to vaccinate
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Financial Barriers to SUD Recovery
Endpoint domain: Resource use
Endpoint subdomain: Societal/carer burden
Primary endpoint: occurrence and severity of side effects
Endpoint domain: Adverse events/effects
Primary endpoint: Diarrhoea rate of all grades
Endpoint domain: Adverse events/effects
Primary endpoint: Surgical outcomes of pelvic exenteration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: incidence of POAF
Endpoint domain: Adverse events/effects
Primary endpoint: Neuropsychological Testing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Brainstem Auditory Evoked Response (BAER)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in airway smooth muscle mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Combined incidence of HPV-related high-grade diseases
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Combined incidence of persistent HPV infections for no less than 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Function of endothelial progenitor cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Tolerated Dose of MCS110
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Body Awareness
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Differential expression of CD133
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Feasibility of dietary intervention
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Post-operative creatinine clearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: renal endpoint
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Tolerability of Ablation
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants With Local, Regional, and/or Distant Failure
Endpoint domain: Mortality/survival
Primary endpoint: Fluorescence anisotropy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: toxicity measured by the CTC Criteria
Endpoint domain: Adverse events/effects
Primary endpoint: Time of Acidosis Correction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: adverse maternal outcomes
Endpoint domain: Adverse events/effects
Primary endpoint: Parkinson's Disease Quality of Life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Substance Abuse Self-stigma Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Mean Activity Counts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Holgers Classification of Skin Reactions
Endpoint domain: Adverse events/effects
Primary endpoint: Completed participation in baseline survey
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in Alzheimer Disease Evaluation Scales (MMSE, Clock test, IADL)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in vocal and motor tics and disease burden
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in premonitory urge
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Subjective improvement of tics and Quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Intact neonatal survival until term age
Endpoint domain: Mortality/survival
Primary endpoint: Change From Baseline in Weighted Mean Daily Glucose (WMDG)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: time-to-progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: number of missing items of the MACOCHA score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the plasma concentration versus time curve (AUC) of pazopanib
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of postoperative fistulas
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: reduction of mean systolic blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change From Baseline in Brain Fibrillar Beta-Amyloid Protein (Aβ)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Reduction in dysphagia scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in overall quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Changes in ability to carry out activities that require physical actions
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Percentage of Subjects With Mean GH ≤2.5 ng/mL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Normalised IGF-1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Change of Inter-limb volume difference ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the curve (AUC) of plasma drug concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Skeletal muscle radiation attenuation at L3
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical data following surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: occurrence of device related complications
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants with decreased Feeding Related Length of Stay
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Number of participants with Full oral feeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants with hospital readmission for feeding related issues
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Rhinitis Quality of Life Questionnaire score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Rescue Medication Score
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: AUC point estimates of E5501 40 mg tablet
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmax point estimates of E5501 40 mg tablet
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of adverse events associated with vaccine
Endpoint domain: Adverse events/effects
Primary endpoint: Number of prevented diarrhea episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change in Peak Systolic Velocity (PSV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in End Diastolic Velocity (EDV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in Resistive Index (RI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in Volume Flow (VF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in EPIC bowel domain score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in EPIC urinary domain score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Hydration Status Change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean dissection time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Tongue base thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Retropalatal distance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Distance between lingual arteries
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in visceral adipose tissue mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Biodistribution of anti-CD45 monoclonal antibody AHN-12
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Occurrence of primary open angle glaucoma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change in Social Responsiveness Scale Total Scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Number of participants able to complete protocol
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Days without antibiotics
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Supportive Care Needs
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Safety of LV lead at 10 weeks
Endpoint domain: Adverse events/effects
Primary endpoint: Performance of LV lead at 10 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Insulin Release Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Hepatic Glucose Release
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: grade 4 NCI toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: percentage of patients completing treatment
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Duration between 2 blinks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complete healing of reference ulcer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Response using Lugano Criteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HF risk classification
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prescription of antibiotics
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: occurrence of reperfusion injury
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: SP expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients with clinically severe intracranial injury classified at risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: OA structural progression of the index knee
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: OA pain progression of the index knee
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concordance of reported elements of the patient action plan
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Popliteal macrovascular function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Motor-Language (ML) Scale Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of depression
Endpoint domain: Adverse events/effects
Primary endpoint: Prevalence of anxiety
Endpoint domain: Adverse events/effects
Primary endpoint: Prevalence of sexual dysfunction
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of HBeAg(+) Participants Achieving HBeAg Seroconversion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Percentage of HBeAg(-) Participants Achieving HBV DNA Levels <2000 IU/mL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: endorphin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Second Progression Free Survival (PFS2)
Endpoint domain: Mortality/survival
Primary endpoint: Sarcopenia quantified via CT-scan
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the insulin aspart concentration curve from 0-2 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Maximum glucose infusion rate divided by the average glucose infusion rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: State-Trait Inventory of Cognitive and Somatic Anxiety (STICSA)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Endothelin-1 Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in autoregulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: ICP (Intracranial Pressure)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in Short Form 36 Health Survey (SF-36) Mental Component Summary
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Caregiver Burden Scale (CBS)
Endpoint domain: Resource use
Endpoint subdomain: Societal/carer burden
Primary endpoint: Brain Activity using functional MRI (fMRI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neurocognitive battery metrics including IQ
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: fMRI performance in relation to dysglycemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy to recognize emotions in facial expressions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Explicit memory for positive and negative information
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in Albumin/Creatinine Ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Patient Status as Evaluated by Dose Level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Short Term Efficacy as Assessed by Need for Intubation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Accuracy of LCI for diagnosing Hp infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specificity of LCI for diagnosing Hp infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity of LCI for diagnosing Hp infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: All-cause neonatal mortality
Endpoint domain: Mortality/survival
Primary endpoint: Meet specific good groups dietary recommendation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Meet moderate to vigorous physical activity recommendation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sleep about 8 hours/day
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Retina vasculature
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Skeletal malocclusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: RVSP calculated from TEE measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: All cause Neonatal Mortality
Endpoint domain: Mortality/survival
Primary endpoint: Change in Index Memory
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Oral hygiene status in persons with dementia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Caregiver attitude towards oral care
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Efficacy of caregivers in providing oral care
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Microbiological clearance from blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes